Page 19 - Pharmaceutical Firms

Cipla plans acquisitions to take top spot in South African drug market

Cipla has a strong presence in both private and tender markets in South Africa

Billion-dollar pharma cos set to face their first US price negotiations

For taxpayers, the savings could be significant: Negotiations could save the US $36.5 bn from 2026 to 2028, according to Wells Fargo Securities. Drugmakers are suing the government to stop the squeeze

Medical Council guidelines bar doctors from taking freebies from firms

Industry insiders feel this is a step towards implementing and codifying the Uniform Code of Pharmaceutical Marketing Practices

Fierce competition among new drug brands for share of India market

The competitive intensity is high between brands, at a time when volume growth in the domestic pharma market is on a slow lane

Govt orders firm linked to Cameroon cough syrup deaths to stop production

The move comes as Indian regulators step up inspections at drugmakers after cough syrups made in the country were linked to the deaths of dozens of children overseas, denting India's image as the "pha

Allegra, Dolo-650 among 300 pharmaceutical brands to have QR codes

Batches manufactured on and after August 1 will have QR codes printed on the packaging of the selected 300 brands

Over 75% pharma stocks eye breakout; most may see up to 15% upside

Barring, Pfizer, Gland Pharma, and Laurus Labs, all other constituents of Nifty Pharm Index trade over the 200-day simple moving average (SMA),

With biz well positioned, Sun Pharma eyes high single-digit revenue growth

Sun Pharma is looking at high single-digit growth in its consolidated topline this fiscal on the back of robust performance from all its business verticals, according to company's Managing Director Dilip Shanghvi. The Mumbai-based company had reported a consolidated revenue of Rs 43,278 crore in 2022-23. "All our businesses are well-positioned, and we expect high-single-digit consolidated topline growth for FY24," Shanghvi informed shareholders through company's Annual Report for 2022-23. He noted that the global pharmaceutical industry remains quite dynamic, and always buzzing with new avenues for capital deployment. Pursuing any one of these options can place considerable pressure on the balance sheet, he added. "Success is not guaranteed, and it is important for us that we remain thoughtful and selective in deciding which options to pursue. However, we will not shy away from making disproportionate investments to grow our businesses, should an opportunity present itself," Shangh

Lupin's subsidiary, Generic Health gets Tiotropium 18 micrograms approval

The company has received the approval from Therapeutic Goods Administration (TGA)

Indian pharma to grow at 7-9% in FY24 despite regulatory risks: ICRA

ICRA's sample set includes companies such as Dr Reddy's Laboratories, Sun Pharmaceutical Industries, Cipla and Abbott

Action taken against pharma cos following reports of deaths abroad: Centre

The Central Drugs Standard Control Organisation in coordination with state authorities initiated action against pharma companies following reports of deaths and injuries due to their substandard drugs in the Gambia and Uzbekistan, the government informed Lok Sabha on Friday. The Directorate General of Foreign Trade has issued a notification on May 22 this year for amendment in the export policy of cough syrups, making it compulsory for manufacturers to get certificate of analysis from a government-approved laboratory before exporting their products with effect from June 1, Minister of State for Health Bharati Pravin Pawar said in a written reply. Responding to a question, Pawar said that subsequent to reports from Sri Lanka, Gambia and Uzbekistan, the CDSCO in coordination with state drug controllers carried out joint investigations at the manufacturing units of the cough syrups and drugs in question. After deaths of children were reported in the Gambia, the CDSCO in coordination wi

Piramal Pharma's Rs 1,050 crore rights issue gets Sebi's approval

Proceeds of the issue will be utilised for payment of debt and general corporate purposes

Indian drugs regulators took action against 105 pharma firms, says minister

Indian drugs regulators have taken action against 105 pharmaceutical companies after a risk-based inspection and audit of manufacturing plants, the health minister said on Tuesday

Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick

Pharma players with a major exposure to US mkt such as Sun Pharma, Lupin, Zydus Life, Dr Reddy's, Aurobindo, Torrent have been outperformers hitting their 52-week highs over the last couple of weeks

'4IR': The booster pharma majors are taking to improve productivity

Large manufacturers are leveraging new-age technologies and advanced analytics to improve productivity and reduce deviations in production processes

Kin of AP blast victims seek compensation from pharmaceutical company

Relatives of two persons who died in an explosion at a pharma company in Anakapalli district are demanding compensation from the employer. The duo succumbed to chemical burns they suffered in the blast at Sahiti Pharma company, while undergoing treatment at a hospital in Visakhapatnam on Friday evening. "Around 30 relatives of the deceased persons are at the company now. They are demanding compensation from the company side," a police official said on Saturday. The government has announced ex-gratia of Rs 25 lakh lakh each for the deceased persons. Meanwhile, four injured persons were shifted from KGH Hospital to Indus Hospital for better treatment, said Anakapalli district superintendent of police K. V. Murali Krishna, adding that one person continues to undergoing ICU treatment at KGH Hospital. The company officials are in touch with the family members of the injured persons to provide support for their treatment. Further, he said the company has insured its employees and there

Govt planning more crackdowns on vitamin and mineral combination drugs

The government banned 14 FDCs in June that affected around Rs 824 crore of the domestic pharmaceuticals market

Indian firm used toxic industrial-grade ingredient in cough syrups

The two sources said the syrup was made with industrial-grade PG, a toxic material widely used in liquid detergents, antifreeze, paints or coatings, and to enhance the effectiveness of pesticides

Facing higher scrutiny, IPA plans monthly meetings with members on quality

Data suggests that Indian sites received fewer OAIs in the first six months of 2023

Spiriva approval gives earnings visibility to Lupin; valuations expensive

Lupin's shares declined 4.5 per cent in Thursday's intra-day trade